Results 151 to 160 of about 63,243 (270)

EANM recommendations based on systematic analysis of small animal radionuclide imaging in inflammatory musculoskeletal diseases. [PDF]

EJNMMI Res, 2021
Aarntzen EHJG, Noriega-Álvarez E, Artiko V, Dias AH, Gheysens O, Glaudemans AWJM, Lauri C, Treglia G, van den Wyngaert T, van Leeuwen FWB, Terry SYA.   +10 more
europepmc   +1 more source

When Meningioma Travels: Rare Extracranial Metastasis—Case and Review

Clinical Case Reports, Volume 14, Issue 4, April 2026.
Recurrent atypical meningioma with anaplastic transformation (Grade 3) developed delayed hepatic metastasis 12 years after diagnosis. Biopsy confirmed metastatic meningioma. Treatment with Sandostatin and Everolimus stabilized disease before progression, highlighting the need for long‐term surveillance in high‐risk cases.
Tala Najdi, Sami Abi Farraj, Pierre El Sett, Clarisse Kattan, Antoine El Sett, Antoine Chartouni, Patrick Ghorayeb, Ghadi Dagher, Rhea Khazen, Fares Azoury, Joseph Kattan, Hampig Kourie   +11 more
wiley   +1 more source

Evaluation of thallium-201 scanning for detection of latent coronary artery disease [PDF]

The use of thallium imaging as a noninvasive method to accurately screen shuttle passengers for latent coronary artery disease was investigated. All radionuclide procedures were performed using an Anger type camera with a high resolution collimator.
Deboer, L., Jhingran, S., Johnson, P. C., Leblanc, A.   +3 more
core   +1 more source

Ultrasmall Au10–12 Nanoclusters: A Novel Platform for 223Ra‐Targeted Tumor α‐Therapy

Exploration, Volume 6, Issue 2, April 2026.
Encapsulating 223Ra in Au10‐12 nanoclusters and functionalizing them with RGD peptides enables targeted α‐therapy and immune microenvironment remodeling in non‐osseous tumors like triple‐negative breast cancer. This study establishes a foundational framework for novel 223Ra‐labeled α‐radiopharmaceuticals and shows strong potential for clinical ...
Yifei Jiang, Huizhen Yang, Guoping Jia, Wangxi Hai, Rongyi Huang, Peng Wang, Min Zhang, Danni Li, Yizhou Chen, Xiao Li, Biao Li, Chunfu Zhang   +11 more
wiley   +1 more source

Hypoxia-augmented chemotherapy potentiates imaging-guided combinatorial radionuclide-sonodynamic therapy for pancreatic cancer

Journal of Nanobiotechnology
Radionuclide therapy and chemotherapy are effective for pancreatic cancer, yet their efficacy is often limited by tumor hypoxia. In this study, manganese porphyrin (MnTTP) and tirapazamine (TPZ) were encapsulated in polylactic-co-glycolic acid (PLGA ...
Jie An, Kaile Chu, Xirong Li, Huizhu Ma, Qin Zhou, Chenliang Niu, Jie Gao, Junping Lv, Jianbo Cao, XinYu Zhang, Haitao Zhou, Hongliang Wang, Min Li, Zhifang Wu, Sijin Li   +14 more
doaj   +1 more source

25 Years of “Loop” Radiochemistry for PET Imaging

Journal of Labelled Compounds and Radiopharmaceuticals, Volume 69, Issue 4-6, April‐May 2026.
While conventional methods to 11C‐ and 18F‐labelled radiopharmaceuticals utilize a vial‐based approach, in the past quarter‐century, a modern, efficient, and cleaner “loop method” has been developed. The radiochemical diversity of reactions synthesized by the loop method are shown.
Emily Murrell, Sahil Khan, Neil Vasdev
wiley   +1 more source

MEDICINA NUCLEAR EN EL TRACTO NEFROURINARIO

Revista Chilena de Radiología, 2002
En el diagnóstico por imágenes de las enfermedades del sistema nefrourológico, la Medicina Nuclear juega un rol importante en determinadas patologías.
M. Josefina Jofré M, Paulina Sierralta C   +1 more
doaj  

Antibody–Drug Conjugates in Oncology: Principles, Clinical Development, and Future Directions

MedComm, Volume 7, Issue 4, April 2026.
Antibody–drug conjugates integrate antibody targeting with potent cytotoxic payloads to enable precision cancer therapy. Their clinical performance depends on coordinated optimization of engineering design, tumor antigen biology, and treatment strategy. Lessons from uro‐oncological malignancies illustrate how ADCs can be effectively developed, combined,
Bisheng Cheng, Lanqi Gong, Zongwei Wang, Peidan Peng, Kewei Xu, Hai Huang, Peng Wu   +6 more
wiley   +1 more source

Targeted Therapies for Each Subtype of Breast Cancer

MedComm, Volume 7, Issue 4, April 2026.
This review systematically summarizes the advances in targeted therapies for the three major molecular subtypes of breast cancer (BC), highlighting key strategies, agents, and clinical progress to guide personalized treatment. HR‐positive (luminal) BC: Dominated by estrogen receptor (ER) signaling, with endocrine therapies as the cornerstone—including ...
Aiyu Liu, Puchao Peng, Yeke Zhu, Qiuwen Fei, Weiwei Liu, Shizhen Zhang   +5 more
wiley   +1 more source

Cancer-Associated Fibroblasts as Players in Cancer Development and Progression and Their Role in Targeted Radionuclide Imaging and Therapy. [PDF]

Cancers (Basel), 2021
Koustoulidou S, Hoorens MWH, Dalm SU, Mahajan S, Debets R, Seimbille Y, de Jong M.   +6 more
europepmc   +1 more source